Researchers assessed the clinical usefulness of specific biomarkers in risk stratification for vascular complications Identifying biomarkers that predict risk for pulmonary hypertension or ischemic digital lesions may be useful in monitoring the development of systemic sclerosis in patients.
The World Health Organization has released interim guidance for long-term care facilities aimed at preventing COVID-19.
Patients with nonvalvular atrial fibrillation who were prescribed apixaban vs rivaroxaban had a lower rate of ischemic stroke or systemic embolism and bleeding.
The improvements in estimated and total body bone mineral density observed with statin treatment may be partly accounted for by their low-density lipoprotein cholesterol-lowering effect.
The treatment of patients with dual antiplatelet therapy after a percutaneous coronary intervention was found to be associated with a reduction in de novo atherothrombotic ischemic events.
Treatment with liraglutide for type 2 diabetes was not associated with an increased risk for hospitalization for heart failure (HF) or cardiovascular death in patients with vs without a history of HF.
A structural abnormality on cardiac magnetic resonance imaging may be a predictor of major adverse cardiac events in patients with nonsustained ventricular tachycardia and ventricular tachycardia/sudden cardiac death.
18F-sodium fluoride coronary positron emission tomography may help predict the development of myocardial infarction in patients with advanced coronary artery disease.
Emergency Medical Services personnel implement a broad spectrum of approaches to out-of-hospital cardiac arrest.
Time to telemedicine diagnosis was found to be a useful parameter in assessing the effectiveness of telemedicine in patients who have experienced myocardial infarction.
